SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-24-009052
Filing Date
2024-03-22
Accepted
2024-03-22 16:17:44
Documents
18
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A eton20231130_10ka.htm   iXBRL 10-K/A 40082
2 EXHIBIT 23.1 ex_642689.htm EX-23.1 2373
3 EXHIBIT 31.1 ex_642690.htm EX-31.1 8917
4 EXHIBIT 31.2 ex_642691.htm EX-31.2 8871
5 EXHIBIT 32.1 ex_642692.htm EX-32.1 6228
  Complete submission text file 0001437749-24-009052.txt   270795

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA eton-20231231.xsd EX-101.SCH 3409
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eton-20231231_def.xml EX-101.DEF 16364
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE eton-20231231_lab.xml EX-101.LAB 22317
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eton-20231231_pre.xml EX-101.PRE 17239
21 EXTRACTED XBRL INSTANCE DOCUMENT eton20231130_10ka_htm.xml XML 6332
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38738 | Film No.: 24775481
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)